Ad
ALNY Short Information Alnylam Pharmaceuticals Inc.
home / stock / alny / alny short
Short Information | Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY)
| Twenty Trading Day Totals | |
|---|---|
| Total Shorted Volume | 2,102,782 |
| Total Actual Volume | 13,037,364 |
| Short Trends | |
|---|---|
| Cover Days | 20 |
| Short Days | 0 |
| No Change Days | 0 |
| Averages | |
|---|---|
| Average Short Volume | 105,139 |
| Average Short Percentage | 15.84% |
Is there a ALNY Short Squeeze or Breakout about to happen?
See the ALNY Short Analysis for free Sign up or Login
Powered by Squeeze Report
ALNY Twenty Trading Day's Volume to Short Volume Chart
ALNY Twenty Trading Day Price Chart
ALNY Short Data Results Days
| Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
|---|---|---|---|---|---|---|---|
| 01-15-2025 | $244 | $251.01 | $255.295 | $244 | 833,805 | 192,192 | 23.05% |
| 01-14-2025 | $258.74 | $240.51 | $259.6 | $240.02 | 783,774 | 134,909 | 17.21% |
| 01-13-2025 | $240 | $258.27 | $261.86 | $236.87 | 1,224,383 | 314,703 | 25.7% |
| 01-10-2025 | $237.17 | $237.98 | $240.165 | $232.82 | 706,146 | 120,933 | 17.13% |
| 01-08-2025 | $236.34 | $240.55 | $240.65 | $234.106 | 653,987 | 52,459 | 8.02% |
| 01-07-2025 | $234 | $235.95 | $239.23 | $232.98 | 628,968 | 92,065 | 14.64% |
| 01-06-2025 | $234.09 | $233.15 | $237.49 | $231 | 561,533 | 79,532 | 14.16% |
| 01-03-2025 | $232.59 | $234.28 | $235.525 | $232.345 | 411,197 | 65,048 | 15.82% |
| 01-02-2025 | $237.92 | $233.62 | $239.99 | $232.25 | 392,740 | 60,000 | 15.28% |
| 12-31-2024 | $237.26 | $235.31 | $238.44 | $235.16 | 370,137 | 52,186 | 14.1% |
| 12-30-2024 | $235.73 | $236.01 | $236.95 | $233 | 382,384 | 60,917 | 15.93% |
| 12-27-2024 | $241.81 | $237.97 | $243.61 | $237.15 | 342,916 | 44,067 | 12.85% |
| 12-26-2024 | $241.78 | $242.5 | $244.82 | $240.43 | 358,611 | 53,825 | 15.01% |
| 12-24-2024 | $241.7 | $243.25 | $243.895 | $236.7 | 253,070 | 33,310 | 13.16% |
| 12-23-2024 | $244.63 | $242.26 | $244.64 | $237.12 | 718,097 | 102,519 | 14.28% |
| 12-20-2024 | $239.45 | $245.44 | $247.21 | $235.93 | 1,663,571 | 166,240 | 9.99% |
| 12-19-2024 | $238.11 | $238.87 | $242.87 | $233.41 | 975,521 | 146,078 | 14.97% |
| 12-18-2024 | $245.67 | $237.92 | $247.05 | $237.25 | 543,219 | 88,399 | 16.27% |
| 12-17-2024 | $242.7 | $246.58 | $249.58 | $240.4186 | 634,408 | 150,489 | 23.72% |
| 12-16-2024 | $246.44 | $243.99 | $247.9275 | $242.13 | 598,897 | 92,911 | 15.51% |
News, Short Squeeze, Breakout and More Instantly...
Alnylam Pharmaceuticals Inc. Company Name:
ALNY Stock Symbol:
NASDAQ Market:
Alnylam Pharmaceuticals Inc. Website:
Ad
-
– Full Year 2024 Preliminary Net Product Revenues of $1,646 Million for ONPATTRO ® , AMVUTTRA ® , GIVLAARI ® , and OXLUMO ® , Representing 33% Annual Growth – – 2025 Combined Net Product Revenue Guidance** of $2,050 Million to $2,25...
-
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present a company overview and participate in a Q&A session at the 43 rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 at 9:45 am PT (12:45 pm...
-
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present a company overview at the Piper Sandler 36 th Annual Healthcare Conference on Thursday, December 5, 2024 at 11:00 am ET at the Lotte New York Palace Hotel in New...